Canine Biologics Revenue
Biotechnology Research • 
Denver, Colorado, United States • 1-10 Employees
Canine Biologics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at Canine Biologics
Jennifer M. Brauns
Executive Vice President of Sales & Marketing
Company overview
| Headquarters | 2145 Clermont Street, Denver, CO 80222, US |
| Phone number | +17204633206 |
| Website | |
| Employees | 1-10 |
| Socials |
About Canine Biologics
We are dedicated to developing specialty nutritional systems designed to support dogs and cats with critical health conditions. From the ICU (enteral nutrition system for tube and syringe feeding for dogs and cats) to a unique nutrition system for dogs battling cancer, we know we can help with our innovative approaches. Our company is guided by a team of dedicated, animal-loving Veterinarians with PhDs in Oncology and Nutrition and biochemists who simply refused to accept that the nutrition status-quo was good enough. We help dogs with cancer continue to have the energy and vitality to run, play and love and dogs and cats in critical care settings to have their best outcomes.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Canine Biologics has never raised funding before.
Canine Biologics Tech Stack
Discover the technologies and tools that power Canine Biologics's digital infrastructure, from frameworks to analytics platforms.
CDN
Security
South Africa
Australia
BelgiumFrequently asked questions
4.8
40,000 users
